ClinicalTrials.gov for Facilitating Rapid Understanding of Potential Harms of New Drugs: The Case of Checkpoint Inhibitors

Documenti analoghi

• Reporting “Basic Results” in ClinicalTrials.gov
  di: Tse, Tony, et al.
  Pubblicazione: (2009)
• ClinicalTrials.gov and Drugs@FDA: A comparison of results reporting for new drug approval trials
  di: Schwartz, Lisa M., et al.
  Pubblicazione: (2016)
• Update on Registration of Clinical Trials in ClinicalTrials.gov
  di: Tse, Tony, et al.
  Pubblicazione: (2009)
• Trial Reporting in ClinicalTrials.gov — The Final Rule
  di: Zarin, Deborah A., et al.
  Pubblicazione: (2016)
• Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov
  di: Bourgeois, Florence T., et al.
  Pubblicazione: (2010)